|
|
|
|
5 Days
sidebar My mother-in-law received 5 days of oral levofloxacin (Levaquin) for a urinary tract infection.This was followed by 2 months of C. difficile diarrhea, which was treated with metronidazole (Flagyl) and vancomycin. The diarrhea recurred after...
|
|
|
Wockhardt gets US FDA approval for antibacterial Levofloxacin
Wockhardt has received tentative approval from the US FDA for marketing 250mg, 500mg and 750mg tablets of Levofloxacin, which is used for treatment in a broad spectrum of bacterial infections.Levofloxacin is the generic name for the brand Levaquin,...
|
|
|
Levaquin Plaintiffs Seek To Pry Docs From J&J's Hands
Plaintiffs embroiled in multidistrict product liability litigation over Johnson & Johnsons antibiotic Levaquin have asked a federal judge to force the defendants to relinquish 1,500 they have tried to shield from discovery.On Wednesday, plaintiffs...
|
|
|
Feds accuse J&J of kickback scheme with nursing home pharmacy company
BOSTON-The announced last week that it filed a lawsuit against , alleging the drugmaker paid millions of dollars in kickbacks to Omnicare Inc., a pharmacy company that dispenses drugs in nursing homes.In response, J&J has asserted that its actions were ...
|
|
|
Brand Name Drug Price Increases Deemed Extraordinary
If you have more to say, post a comment below!Millions of Americans do not have insurance that covers prescription medications! They are being hammered by rapidly rising drug costs. What makes these skyrocketing prices so painful is that they come at a...
|
|
|
U.S. accuses J&J of kickbacks to Omnicare
Back when the U.S.Department of Justice settled claims against Omnicare, the nursing home services company, word was that Johnson & Johnson would be the next pharma company in line for government action. That's proven to be the case, as the government...
|
|
|
Johnson&Johnson accused of paying kickbacks to pharmacy chain Omnicare
AP FILE PHOTO Johnson & Johnson, the New Brunswick-based health care giant, allegedly paid millions of dollars in kickbacks to influence the prescriptions one of the nations largest pharmacies wrote for nursing home patients, according to a complaint filed...
|
|
|
Johnson&Johnson accused of paying kickbacks to pharmacy chain Omnicare
AP FILE PHOTO Johnson & Johnson, the New Brunswick-based health care giant, allegedly paid millions of dollars in kickbacks to influence the prescriptions one of the nations largest pharmacies wrote for nursing home patients, according to a complaint filed...
|
|
|
Johnson & Johnson Accused of Drug Kickbacks
Johnson & Johnson paid kickbacks to the nations largest nursing home pharmacy to increase the number of elderly patients taking the antipsychotic Risperdal and several other medications, according to a complaint filed Friday by the office of the United...
|
|
|
1/15/10 - Wockhardt wins FDA tentative approval for antibiotic drug
Wockhardt wins FDA tentative approval for antibiotic drug - January 15, 2010 Pharmacy Article Jan 15, 2010 (Datamonitor via COMTEX) Wockhardt has received tentative approval from the FDA for marketing the 250mg, 500mg and 750mg tablets of levofloxacin, which is...
|
|
|
Wockhardt wins FDA tentative approval for antibiotic drug
(Datamonitor via COMTEX) Wockhardt has received tentative approval from the FDA for marketing the 250mg, 500mg and 750mg tablets of levofloxacin, which is used for treatment in a broad spectrum of bacterial infections.Levofloxacin is the generic name for the...
|
|
|
Wockhardt receives FDA approval for antibacterial Levofloxacin
Wockhardt, one of the leading pharmaceutical and biotechnology companies from India has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing the 250mg, 500mg and 750mg tablets of Levofloxacin, which is used...
|
|
|
1/13/10 - FDA approves Wockhardt's antibacterial Levofloxacin
- India-based pharmaceutical and biotechnology major Wockhardt Ltd (BOM:532300) said today that the US Food and Drug Administration (FDA) approved for marketing the 250 mg, 500 mg and 750 mg tablets of Levofloxacin for treatment of bacterial infections.
|
|
|
FDA approves Wockhardt's antibacterial Levofloxacin
- India-based pharmaceutical and biotechnology major Wockhardt Ltd (BOM:532300) said today that the US Food and Drug Administration (FDA) approved for marketing the 250 mg, 500 mg and 750 mg tablets of Levofloxacin for treatment of bacterial infections.
|
|
|
Wockhardt gets US FDA's tentative approval to market Levofloxacin tabs
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing the 250mg, 500mg and 750mg tablets of Levofloxacin, which is used for treatment in a broad spectrum of...
|
|
|
Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquir
WALTHAM, Mass.The new Pharmacor report entitled Community-Acquired Pneumonia finds that generic erosion of levofloxacin (Johnson & Johnson's Levaquin, Sanofi-Aventis's Tavanic and Daiichi Sankyo's Cravit), moxifloxacin (Bayer/Merck/Shionogi's...
|
